Shire plc Joins National Pharmaceutical Council as Newest Member

On August 3rd, the National Pharmaceutical Council, a health policy research organization, announced MBBP client Shire plc as a new member. Dr. Jeffrey M. Jonas, Senior VP, Specialty Pharmaceuticals R&D, will serve as Shire’s representative on the NPC board of directors. In a recent press release, Dr. Jonas describes Shire’s view on the new membership:

Shire is very supportive of NPC’s focus on evidence-based medicine and on policy research related to comparative effectiveness research, pharmaceutical innovation and the value of medicines. We’re pleased to be a part of this organization and look forward to working with NPC on issues affecting the pharmaceutical industry.

In becoming an NPC member, Shire joins with other companies such as Bristol-Myers Squibb Company, GlaxoSmithKline, Johnson & Johnson, and Merck & Co., Inc.

Please visit Shire for more information or visit the National Pharmaceutical Council to view the full press release.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s